病毒·非病毒載體的全球市場:2024年

2023年全球病毒與非病毒載體市場規模為5,5185萬美元。

預計到 2030 年，市場規模將達到 35.05 億美元，2024-2030 年預測期間複合年增長率為 31.84%。

2023年北美病毒和非病毒載體市場規模為2.32億美元。預計到 2030 年，該市場將達到 14.23 億美元，2024 年至 2030 年的預測期間複合年增長率為 31%。

2023 年亞太地區病毒和非病毒載體市場規模達 1.41 億美元。預計到 2030 年，該市場將達到 9.83 億美元，2024-2030 年預測期間複合年增長率為 33.67%。

全球領先的病毒和非病毒載體公司包括 Lonza、Thermo Fisher Scientific、VectorBuilder、GenScript Biotech、Gene Chem 和 Revvity。 2023年，全球前5名供應商將佔銷售額約62.03%。

本報告提供全球病毒·非病毒載體市場相關調查，提供市場概要，以及各類型，各用途，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

• 調查範圍
• 各類型市場分析
• 各用途市場
• 前提與限制
• 調查目的
• 對象年

第2章 全球成長趨勢

• 全球病毒·非病毒載體市場預測(2019年～2030年)
• 全球病毒·非病毒載體的成長趨勢，各地區
• 病毒·非病毒載體市場動態

第3章 由於主要加入企業的競爭情形

第4章 病毒·非病毒載體的明細資料，各類型

• 全球病毒·非病毒載體的市場規模實際成果，各類型(2019年～2024年)
• 全球病毒·非病毒載體的市場規模預測，各類型(2025年～2030年)

第5章 病毒·非病毒載體的明細資料，各用途

• 全球病毒·非病毒載體的市場規模實際成果，各用途(2019年～2024年)
• 全球病毒·非病毒載體的市場規模預測，各用途(2025年～2030年)

第6章 北美

第7章 歐洲

第8章 亞太地區

第9章 南美

第10章 中東·非洲

第11章 主要人企業俄文件

• Thermo Fisher Scientific
• Lonza
• Azenta Life Sciences
• Revvity
• VectorBuilder
• Takara Bio
• GenScript Biotech
• Gene Chem
• Geno Meditech
• PackGene Biotech
• VIROVEK
• OriGen
• Vector BioLabs

第12章 分析師的觀點/結論

第13章 附錄

The global Viral and Non-viral Vector market was valued at US$ 551.85 million in 2023 and is anticipated to reach US$ 3505 million by 2030, witnessing a CAGR of 31.84% during the forecast period 2024-2030.

North American market for Viral and Non-viral Vector is estimated to increase from $ 232 million in 2023 to reach $ 1423million by 2030, at a CAGR of 31% during the forecast period of 2024 through 2030.

Asia-Pacific market for Viral and Non-viral Vector is estimated to increase from $ 141 million in 2023 to reach $ 983 million by 2030, at a CAGR of 33.67% during the forecast period of 2024 through 2030.

The major global companies of Viral and Non-viral Vector include Lonza, Thermo Fisher Scientific, VectorBuilder, GenScript Biotech, Gene Chem, Revvity, etc. In 2023, the world's top five vendors accounted for approximately 62.03 % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Viral and Non-viral Vector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral and Non-viral Vector.

The Viral and Non-viral Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral and Non-viral Vector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral and Non-viral Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

• Thermo Fisher Scientific
• Lonza
• Azenta Life Sciences
• Revvity
• VectorBuilder
• Takara Bio
• GenScript Biotech
• Gene Chem
• Geno Meditech
• PackGene Biotech
• VIROVEK
• OriGen
• Vector BioLabs

Segment by Type

• AAV
• Lentiviruses
• Retroviruses
• Adenoviruses
• DNA Plasmids
• Others

Segment by Application

• Pharmaceutical and Biopharmaceutical Companies
• Academics and Research Institutes
• Others

By Region

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Rest of Europe
• South America
• Brazil
• Rest of South America
• Middle East & Africa
• Middle East
• Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Viral and Non-viral Vector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Viral and Non-viral Vector Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 AAV
  • 1.2.3 Lentiviruses
  • 1.2.4 Retroviruses
  • 1.2.5 Adenoviruses
  • 1.2.6 DNA Plasmids
• 1.3 Market by Application
  • 1.3.1 Global Viral and Non-viral Vector Market Growth by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Pharmaceutical and Biopharmaceutical Companies
  • 1.3.3 Academics and Research Institutes
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Viral and Non-viral Vector Market Perspective (2019-2030)
• 2.2 Global Viral and Non-viral Vector Growth Trends by Region
  • 2.2.1 Global Viral and Non-viral Vector Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Viral and Non-viral Vector Historic Market Size by Region (2019-2024)
  • 2.2.3 Viral and Non-viral Vector Forecasted Market Size by Region (2025-2030)
• 2.3 Viral and Non-viral Vector Market Dynamics
  • 2.3.1 Viral and Non-viral Vector Industry Trends
  • 2.3.2 Viral and Non-viral Vector Market Drivers
  • 2.3.3 Viral and Non-viral Vector Market Challenges
  • 2.3.4 Viral and Non-viral Vector Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Viral and Non-viral Vector Players by Revenue
  • 3.1.1 Global Top Viral and Non-viral Vector Players by Revenue (2019-2024)
  • 3.1.2 Global Viral and Non-viral Vector Revenue Market Share by Players (2019-2024)
• 3.2 Global Viral and Non-viral Vector Market by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players Ranking by Viral and Non-viral Vector Revenue
• 3.4 Global Viral and Non-viral Vector Market Concentration Ratio
  • 3.4.1 Global Viral and Non-viral Vector Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Viral and Non-viral Vector Revenue in 2023
• 3.5 Global Key Players of Viral and Non-viral Vector Head office and Area Served
• 3.6 Global Key Players of Viral and Non-viral Vector, Product
• 3.7 Global Key Players of Viral and Non-viral Vector, Founded Date
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Viral and Non-viral Vector Breakdown Data by Type

• 4.1 Global Viral and Non-viral Vector Historic Market Size by Type (2019-2024)
• 4.2 Global Viral and Non-viral Vector Forecasted Market Size by Type (2025-2030)

5 Viral and Non-viral Vector Breakdown Data by Application

• 5.1 Global Viral and Non-viral Vector Historic Market Size by Application (2019-2024)
• 5.2 Global Viral and Non-viral Vector Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Viral and Non-viral Vector Market Size (2019-2030)
• 6.2 North America Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 6.3 North America Viral and Non-viral Vector Market Size by Country (2019-2024)
• 6.4 North America Viral and Non-viral Vector Market Size by Country (2025-2030)
• 6.5 United States
• 6.6 Canada
• 6.7 Mexico

7 Europe

• 7.1 Europe Viral and Non-viral Vector Market Size (2019-2030)
• 7.2 Europe Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 7.3 Europe Viral and Non-viral Vector Market Size by Country (2019-2024)
• 7.4 Europe Viral and Non-viral Vector Market Size by Country (2025-2030)
• 7.5 Germany
• 7.6 France
• 7.7 U.K.
• 7.8 Italy
• 7.9 Russia
• 7.10 Spain

8 Asia-Pacific

• 8.1 Asia-Pacific Viral and Non-viral Vector Market Size (2019-2030)
• 8.2 Asia-Pacific Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 8.3 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2019-2024)
• 8.4 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2025-2030)
• 8.5 China
• 8.6 Japan
• 8.7 South Korea
• 8.8 Southeast Asia
• 8.9 India
• 8.10 Australia

9 South America

• 9.1 South America Viral and Non-viral Vector Market Size (2019-2030)
• 9.2 South America Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 9.3 South America Viral and Non-viral Vector Market Size by Country (2019-2024)
• 9.4 South America Viral and Non-viral Vector Market Size by Country (2025-2030)
• 9.5 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Viral and Non-viral Vector Market Size (2019-2030)
• 10.2 Middle East & Africa Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 10.3 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2019-2024)
• 10.4 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2025-2030)
• 10.5 Middle East
• 10.6 Africa

11 Key Players Profiles

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Company Details
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific Viral and Non-viral Vector Introduction
  • 11.1.4 Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2019-2024)
  • 11.1.5 Thermo Fisher Scientific Recent Development
• 11.2 Lonza
  • 11.2.1 Lonza Company Details
  • 11.2.2 Lonza Business Overview
  • 11.2.3 Lonza Viral and Non-viral Vector Introduction
  • 11.2.4 Lonza Revenue in Viral and Non-viral Vector Business (2019-2024)
  • 11.2.5 Lonza Recent Development
• 11.3 Azenta Life Sciences
  • 11.3.1 Azenta Life Sciences Company Details
  • 11.3.2 Azenta Life Sciences Business Overview
  • 11.3.3 Azenta Life Sciences Viral and Non-viral Vector Introduction
  • 11.3.4 Azenta Life Sciences Revenue in Viral and Non-viral Vector Business (2019-2024)
  • 11.3.5 Azenta Life Sciences Recent Development
• 11.4 Revvity
  • 11.4.1 Revvity Company Details
  • 11.4.2 Revvity Business Overview
  • 11.4.3 Revvity Viral and Non-viral Vector Introduction
  • 11.4.4 Revvity Revenue in Viral and Non-viral Vector Business (2019-2024)
• 11.5 VectorBuilder
  • 11.5.1 VectorBuilder Company Details
  • 11.5.2 VectorBuilder Business Overview
  • 11.5.3 VectorBuilder Viral and Non-viral Vector Introduction
  • 11.5.4 VectorBuilder Revenue in Viral and Non-viral Vector Business (2019-2024)
  • 11.5.5 VectorBuilder Recent Development
• 11.6 Takara Bio
  • 11.6.1 Takara Bio Company Details
  • 11.6.2 Takara Bio Business Overview
  • 11.6.3 Takara Bio Viral and Non-viral Vector Introduction
  • 11.6.4 Takara Bio Revenue in Viral and Non-viral Vector Business (2019-2024)
  • 11.6.5 Takara Bio Recent Development
• 11.7 GenScript Biotech
  • 11.7.1 GenScript Biotech Company Details
  • 11.7.2 GenScript Biotech Business Overview
  • 11.7.3 GenScript Biotech Viral and Non-viral Vector Introduction
  • 11.7.4 GenScript Biotech Revenue in Viral and Non-viral Vector Business (2019-2024)
  • 11.7.5 GenScript Biotech Recent Development
• 11.8 Gene Chem
  • 11.8.1 Gene Chem Company Details
  • 11.8.2 Gene Chem Business Overview
  • 11.8.3 Gene Chem Viral and Non-viral Vector Introduction
  • 11.8.4 Gene Chem Revenue in Viral and Non-viral Vector Business (2019-2024)
• 11.9 Geno Meditech
  • 11.9.1 Geno Meditech Company Details
  • 11.9.2 Geno Meditech Business Overview
  • 11.9.3 Geno Meditech Viral and Non-viral Vector Introduction
  • 11.9.4 Geno Meditech Revenue in Viral and Non-viral Vector Business (2019-2024)
• 11.10 PackGene Biotech
  • 11.10.1 PackGene Biotech Company Details
  • 11.10.2 PackGene Biotech Business Overview
  • 11.10.3 PackGene Biotech Viral and Non-viral Vector Introduction
  • 11.10.4 PackGene Biotech Revenue in Viral and Non-viral Vector Business (2019-2024)
• 11.11 VIROVEK
  • 11.11.1 VIROVEK Company Details
  • 11.11.2 VIROVEK Business Overview
  • 11.11.3 VIROVEK Viral and Non-viral Vector Introduction
  • 11.11.4 VIROVEK Revenue in Viral and Non-viral Vector Business (2019-2024)
  • 11.11.5 VIROVEK Recent Development
• 11.12 OriGen
  • 11.12.1 OriGen Company Details
  • 11.12.2 OriGen Business Overview
  • 11.12.3 OriGen Viral and Non-viral Vector Introduction
  • 11.12.4 OriGen Revenue in Viral and Non-viral Vector Business (2019-2024)
• 11.13 Vector BioLabs
  • 11.13.1 Vector BioLabs Company Details
  • 11.13.2 Vector BioLabs Business Overview
  • 11.13.3 Vector BioLabs Viral and Non-viral Vector Introduction
  • 11.13.4 Vector BioLabs Revenue in Viral and Non-viral Vector Business (2019-2024)
  • 11.13.5 Vector BioLabs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer 119

List of Tables

• Table 1. Global Viral and Non-viral Vector Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
• Table 2. Global Viral and Non-viral Vector Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
• Table 3. Global Viral and Non-viral Vector Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
• Table 4. Global Viral and Non-viral Vector Market Size by Region (2019-2024) & (US$ Million)
• Table 5. Global Viral and Non-viral Vector Market Share by Region (2019-2024)
• Table 6. Global Viral and Non-viral Vector Forecasted Market Size by Region (2025-2030) & (US$ Million)
• Table 7. Global Viral and Non-viral Vector Market Share by Region (2025-2030)
• Table 8. Viral and Non-viral Vector Market Trends
• Table 9. Viral and Non-viral Vector Market Drivers
• Table 10. Viral and Non-viral Vector Market Challenges
• Table 11. Viral and Non-viral Vector Market Restraints
• Table 12. Global Viral and Non-viral Vector Revenue by Players (2019-2024) & (US$ Million)
• Table 13. Global Viral and Non-viral Vector Market Share by Players (2019-2024)
• Table 14. Global Top Viral and Non-viral Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non-viral Vector as of 2023)
• Table 15. Ranking of Global Top Viral and Non-viral Vector Companies by Revenue (US$ Million) in 2023
• Table 16. Global 5 Largest Players Market Share by Viral and Non-viral Vector Revenue (CR5 and HHI) & (2019-2024)
• Table 17. Global Key Players of Viral and Non-viral Vector, Headquarters and Area Served
• Table 18. Global Key Players of Viral and Non-viral Vector, Product
• Table 19. Global Key Players of Viral and Non-viral Vector, Founded Date
• Table 20. Mergers & Acquisitions, Expansion Plans
• Table 21. Global Viral and Non-viral Vector Market Size by Type (2019-2024) & (US$ Million)
• Table 22. Global Viral and Non-viral Vector Revenue Market Share by Type (2019-2024)
• Table 23. Global Viral and Non-viral Vector Forecasted Market Size by Type (2025-2030) & (US$ Million)
• Table 24. Global Viral and Non-viral Vector Revenue Market Share by Type (2025-2030)
• Table 25. Global Viral and Non-viral Vector Market Size by Application (2019-2024) & (US$ Million)
• Table 26. Global Viral and Non-viral Vector Revenue Market Share by Application (2019-2024)
• Table 27. Global Viral and Non-viral Vector Forecasted Market Size by Application (2025-2030) & (US$ Million)
• Table 28. Global Viral and Non-viral Vector Revenue Market Share by Application (2025-2030)
• Table 29. North America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
• Table 30. North America Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)
• Table 31. North America Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)
• Table 32. Europe Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
• Table 33. Europe Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)
• Table 34. Europe Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)
• Table 35. Asia-Pacific Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
• Table 36. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2019-2024) & (US$ Million)
• Table 37. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2025-2030) & (US$ Million)
• Table 38. South America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
• Table 39. South America Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)
• Table 40. South America Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)
• Table 41. Middle East & Africa Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
• Table 42. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)
• Table 43. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)
• Table 44. Thermo Fisher Scientific Company Details
• Table 45. Thermo Fisher Scientific Business Overview
• Table 46. Thermo Fisher Scientific Viral and Non-viral Vector Product
• Table 47. Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 48. Thermo Fisher Scientific Recent Development
• Table 49. Lonza Company Details
• Table 50. Lonza Business Overview
• Table 51. Lonza Viral and Non-viral Vector Product
• Table 52. Lonza Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 53. Lonza Recent Development
• Table 54. Azenta Life Sciences Company Details
• Table 55. Azenta Life Sciences Business Overview
• Table 56. Azenta Life Sciences Viral and Non-viral Vector Product
• Table 57. Azenta Life Sciences Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 58. Azenta Life Sciences Recent Development
• Table 59. Revvity Company Details
• Table 60. Revvity Business Overview
• Table 61. Revvity Viral and Non-viral Vector Product
• Table 62. Revvity Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 63. VectorBuilder Company Details
• Table 64. VectorBuilder Business Overview
• Table 65. VectorBuilder Viral and Non-viral Vector Product
• Table 66. VectorBuilder Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 67. VectorBuilder Recent Development
• Table 68. Takara Bio Company Details
• Table 69. Takara Bio Business Overview
• Table 70. Takara Bio Viral and Non-viral Vector Product
• Table 71. Takara Bio Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 72. Takara Bio Recent Development
• Table 73. GenScript Biotech Company Details
• Table 74. GenScript Biotech Business Overview
• Table 75. GenScript Biotech Viral and Non-viral Vector Product
• Table 76. GenScript Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 77. GenScript Biotech Recent Development
• Table 78. Gene Chem Company Details
• Table 79. Gene Chem Business Overview
• Table 80. Gene Chem Viral and Non-viral Vector Product
• Table 81. Gene Chem Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 82. Geno Meditech Company Details
• Table 83. Geno Meditech Business Overview
• Table 84. Geno Meditech Viral and Non-viral Vector Product
• Table 85. Geno Meditech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 86. PackGene Biotech Company Details
• Table 87. PackGene Biotech Business Overview
• Table 88. PackGene Biotech Viral and Non-viral Vector Product
• Table 89. PackGene Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 90. VIROVEK Company Details
• Table 91. VIROVEK Business Overview
• Table 92. VIROVEK Viral and Non-viral Vector Product
• Table 93. VIROVEK Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 94. VIROVEK Recent Development
• Table 95. OriGen Company Details
• Table 96. OriGen Business Overview
• Table 97. OriGen Viral and Non-viral Vector Product
• Table 98. OriGen Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 99. Vector BioLabs Company Details
• Table 100. Vector BioLabs Business Overview
• Table 101. Vector BioLabs Viral and Non-viral Vector Product
• Table 102. Vector BioLabs Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)
• Table 103. Vector BioLabs Recent Development
• Table 104. Research Programs/Design for This Report
• Table 105. Key Data Information from Secondary Sources
• Table 106. Key Data Information from Primary Sources
• Table 107. Authors List of This Report

List of Figures

• Figure 1. Global Viral and Non-viral Vector Market Size Comparison by Type (2024-2030) & (US$ Million)
• Figure 2. Global Viral and Non-viral Vector Market Share by Type: 2023
• Figure 3. Global Viral and Non-viral Vector Market Share by Type: 2030
• Figure 4. AAV Features
• Figure 5. Global Viral and Non-viral Vector Market Size by Application (2024-2030) & (US$ Million)
• Figure 6. Global Viral and Non-viral Vector Market Share by Application: 2023
• Figure 7. Global Viral and Non-viral Vector Market Share by Application: 2030
• Figure 8. Pharmaceutical and Biopharmaceutical Companies Case Studies
• Figure 9. Academics and Research Institutes Case Studies
• Figure 10. Viral and Non-viral Vector Report Years Considered
• Figure 11. Global Viral and Non-viral Vector Market Size (US$ Million), Year-over-Year: 2019-2030
• Figure 12. Global Viral and Non-viral Vector Market Size, (US$ Million), 2019 VS 2024 VS 2030
• Figure 13. Global Viral and Non-viral Vector Market Share by Region: 2023
• Figure 14. Global Viral and Non-viral Vector Market Share by Region: 2030
• Figure 15. Global Viral and Non-viral Vector Market Share by Players in 2023
• Figure 16. The Top 5 Players Market Share by Viral and Non-viral Vector Revenue in 2023
• Figure 17. The Top 10 Players Market Share by Viral and Non-viral Vector Revenue in 2023
• Figure 18. North America Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 19. North America Viral and Non-viral Vector Market Share by Country (2019-2030)
• Figure 20. United States Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 21. Canada Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 22. Mexico Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 23. Europe Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 24. Europe Viral and Non-viral Vector Market Share by Country (2019-2030)
• Figure 25. Germany Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 26. France Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 27. U.K. Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 28. Italy Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 29. Russia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 30. Spain Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 31. Asia-Pacific Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 32. Asia-Pacific Viral and Non-viral Vector Market Share by Region (2019-2030)
• Figure 33. China Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 34. Japan Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 35. South Korea Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 36. Southeast Asia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 37. India Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 38. Australia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 39. South America Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 40. South America Viral and Non-viral Vector Market Share by Country (2019-2030)
• Figure 41. Brazil Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 42. Middle East & Africa Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 43. Middle East & Africa Viral and Non-viral Vector Market Share by Country (2019-2030)
• Figure 44. Middle East Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 45. Africa Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)
• Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 47. Lonza Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 48. Azenta Life Sciences Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 49. Revvity Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 50. VectorBuilder Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 51. Takara Bio Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 52. GenScript Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 53. Gene Chem Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 54. Geno Meditech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 55. PackGene Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 56. VIROVEK Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 57. OriGen Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 58. Vector BioLabs Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)
• Figure 59. Bottom-up and Top-down Approaches for This Report
• Figure 60. Data Triangulation
• Figure 61. Key Executives Interviewed